Monterona, Alicia N.

HRN: 22-69-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2023
CEFTRIAXONE 1G (VIAL)
10/16/2023
10/23/2023
IV
2g
Q24
Sepsis
Waiting Final Action 
10/16/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/16/2023
10/23/2023
IV
600mg
Q6
Sepsis
Waiting Final Action 
10/20/2023
CLINDAMYCIN 300MG (CAP)
10/20/2023
10/26/2023
PO
600mg
Q6
Infected Wound
Checking Final Appropriateness 
10/22/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/22/2023
10/29/2023
IV
1.5gram
Q6
Infected Wound
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: